DHMi005-A-8

L Delta B2M Clone 6

General

Cell Line

hPSCreg name DHMi005-A-8
Cite as:
DHMi005-A-8 (RRID:CVCL_E3U7)
Alternative name(s)
L Delta B2M Clone 6
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
DHMi005-A-9
(L Delta B2M Clone 11)
DHMi005-A
(Control_L)
IRFMNi001-B-2
(CIone M CIITAKO-B2MKO)
RCPCMi007-A-1
(IPSFF1S deltab2m)
MUSIi001-A-1
(B2M-KO-SFiPSC5, HLA-I-null SFiPSCs)
DHMi005-A-2
(L_FLAG Clone 5)
DHMi005-A-3
(L_FLAG Clone 6)
DHMi005-A-4
(L_FLAG Clone 7)
DHMi005-A-5
(L_mut_FLAG Clone 4)
DHMi005-A-6
(L_mut_FLAG Clone 14)
DHMi005-A-7
(L_mut_FLAG Clone 15)
CHAHESe001-A-1
(CHA-hES NT6 B2M KO#67)
Donor diseases:
age-related macular degeneration
Last update 17th November 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator German Heart Center Munich (DHM)
Owner German Heart Center Munich, Department of Cardiovascular Surgery, Institute Insure
Distributors
Derivation country Germany

External Databases

BioSamples SAMEA114632708
Cellosaurus CVCL_E3U7

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Family history No abnormalities have been described with regard to the family history.
Is the medical history available upon request? no, healthy proband
Is clinical information available? no, healthy proband

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA12738677

Ethics

Also have a look at the ethics information for the parental line DHMi005-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

The source cell information can be found in the parental cell line DHMi005-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
ReLeSR
CO2 Concentration 5 %
Medium mTeSR™ Plus
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
OCT4
Yes
SOX2
Yes
c-MYC
Yes
KLF4
Yes
NANOG
Yes
TRA 1-81
Yes
TRA 1-60
Yes
REX1
Yes
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46 XY
Passage number: 52

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
B2M (target)
Gene knock-out
15q21.1
heterozygous knock-out of one B2M allele, verfied by genomic PCR analysis and Sanger sequencing of the edited and wild-type locus
CRISPR-associated (CRISPR/Cas) System